ALETHEIA THERAPEUTICS
Aletheia Therapeutics provides oncology therapeutics based in Fort Collins, Colorado. It engages in developing and commercializing precision cancer therapies by simultaneously targeting two or more of the following biological targets depending on the make-up of a patients' cancer: DNA repair, T-cell activation, metabolic dysfunction, angiogenesis, apoptosis or inflammation.
ALETHEIA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Oncology Therapeutics
Founded:
2018-01-01
Address:
Fort Collins, Colorado, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
165.01 K USD
Similar Organizations
ARase Therapeutics
Arase Therapeutics is a science-focused oncology company developing therapies that modulate cancer-relevant cell signaling pathways.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Prescient Therapeutics
Prescient Therapeutics is a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic.
More informations about "Aletheia Therapeutics"
Aletheia Therapeutics Company Profile 2024: Valuation, …
Aletheia Therapeutics General Information Description. Provider of oncology therapeutics based in Fort Collins, Colorado. The company engages in developing and commercializing precision cancer therapies by simultaneously …See details»
Aletheia Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Aletheia Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Aletheia Therapeutics - Funding, Financials, Valuation & Investors
Aletheia Therapeutics is a clinical-stage oncology therapeutics company that develops a paradigm shift in the treatment of cancer. Search Crunchbase. ... How much funding has this …See details»
Immune Therapeutics acquires Aletheia Therapeutics - 2019-12-16 ...
Aletheia Therapeutics Aletheia Therapeutics is a clinical-stage oncology therapeutics company that develops a paradigm shift in the treatment of cancer. Acquiring Organization: Immune …See details»
Aletheia Therapeutics - Products, Competitors, Financials, …
Aletheia Therapeutics is a clinical-stage oncology therapeutics company focused on developing approaches for cancer treatment. The company is engaged in research and development …See details»
Aletheia Therapeutics - Company Profile - Tracxn
Aletheia Therapeutics - Developer of therapeutics to treat cancer. Acquired by Immune Therapeutics. Aletheia Therapeutics has 332 competitors.See details»
Aletheia Therapeutics, Inc. in Fort Collins, Colorado - EIN TaxId
Aletheia Therapeutics, Inc. is a corporation in Fort Collins, Colorado. The employer identification number (EIN) for Aletheia Therapeutics, Inc. is 832542717. EIN for organizations is sometimes …See details»
Alethia Biotherapeutics - PitchBook
Developer of monoclonal antibody therapeutics designed to treat clinically relevant disease-specific targets. The company's therapeutics are developed using patented STAR discovery technology and focus on invasive carcinomas …See details»
Aletheia Therapeutics Company Profile | Management and
Find contact information for Aletheia Therapeutics. Learn about their Physicians Clinics, Hospitals & Physicians Clinics market share, competitors, and Aletheia Therapeutics's email format.See details»
ALETHEIA THERAPEUTICS, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ALETHEIA THERAPEUTICS, LLC of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»
Alethia Biotherapeutics
May 21, 2020 Alethia Biotherapeutics Announces Receipt of FDA Authorization to Begin Phase 2 Development for its EMT Inhibitor, AB-16B5 MONTREAL, May 21, 2020 – Alethia …See details»
Aletheia Therapeutics D $21M in equity, sold $165.01K, 4
Aletheia Therapeutics, Inc. Street Address 1 Street Address 2; 1001-A East Harmony Road: 114: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; Fort Collins: …See details»
Aletheia Therapeutics - Crunchbase
Organization. Aletheia Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. …See details»
ALETHEIA THERAPEUTICS, PLLC - Accepted Health Plans and …
ALETHEIA THERAPEUTICS, PLLC Accepted Insurance Health Plans for NPI 1619422102 Counselor - Mental Health in Seattle, WA. NPI Status: Active since August 24, 2016. Contact …See details»
Home | Aletheia
Aletheia's neuroenergetic gene therapies address impaired bioenergetics, which are the common denominator across the entire clinical spectrum of neurodegenerative disease. Lead …See details»
Aletheia BioTherapeutics - Crunchbase Company Profile & Funding
Aletheia BioTherapeutics is a healthcare organization. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Organization. …See details»
Aletheia BioTherapeutics - PitchBook
Is Aletheia BioTherapeutics a private or public company? Aletheia BioTherapeutics is a Private company. What is Aletheia BioTherapeutics’s current revenue? The current revenue for …See details»
Alethia BioTherapeutics - Crunchbase Company Profile & Funding
Nov 2, 2012 Alethia BioTherapeutics, Inc., a biotechnology company, engages in the discovery and development of monoclonal antibody-based therapeutics focusing on the cancer …See details»